NCT02034565View on ClinicalTrials.gov

Phase 1 Bioavailability Study of Apixaban Solution Formulation Relative to Apixaban Tablets in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Healthy Volunteers
Interventions
DRUG

Apixaban

Trial Locations (1)

07753

Mds Pharma Services, Neptune City

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Bristol-Myers Squibb

INDUSTRY

NCT02034565 - Phase 1 Bioavailability Study of Apixaban Solution Formulation Relative to Apixaban Tablets in Healthy Subjects | Biotech Hunter | Biotech Hunter